Skip to main content
. 2012 Feb 17;7(2):e30881. doi: 10.1371/journal.pone.0030881

Figure 2. Increased plasma levels of CXCL9, CXCL10, sIL-2R, and sCD14 distinguish viremic and aviremic HIV subjects from controls.

Figure 2

Supervised hierarchical clustering of plasma CXCL9, CXCL10, sIL-2R, and sCD14 levels measured in viremic (panel A) or aviremic, (panel B) HIV subjects compared to healthy controls. In heat maps, red and blue represent increased and decreased levels relative to the mean level of a biomarker, respectively. Each column and row defines individual patient and biomarkers, respectively.